Research ExplorerScientific StaffCarsten Bokemeyer Publications

Prof. Dr. ID: 68114

Carsten Bokemeyer

graph of relations
Affiliations
601 - 650 out of 794Page size: 50

Publications

  1. 2011

  2. Physical activity, quality of life, and the interest in physical exercise programs in patients undergoing palliative chemotherapy.

    Oechsle, K., Jensen, W., Schmidt, T., Reer, R., Braumann, K-M., De Wit, M. & Bokemeyer, C., 2011, In: SUPPORT CARE CANCER. 19, 5, p. 613-619 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.

    Kobold, S., Isernhagen, J., Hübel, K., Kilic, N., Bogner, C., Frickhofen, N., Bokemeyer, C. & Fiedler, W., 2011, In: BONE MARROW TRANSPL. 46, 8, p. 1053-1056 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Prostatakarzinom

    Hautmann, R., Küfer, R., Bokemeyer, C., Panse, J., Belka, C. & Hinkelbein, W., 2011, Interdisziplinäre Entscheidungswege in der Onkologie: Diagnose- und Therapiealgorithmen mit Erläuterungen. Deutscher Ärzte-Verlag, p. 148-152 5 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  5. Rektumkarzinom

    Schlag, P. M., Panse, J., Bokemeyer, C. & Budach, W., 2011, Interdisziplinäre Entscheidungswege in der Onkologie: Diagnose- und Therapiealgorithmen mit Erläuterungen. Deutscher Ärzte-Verlag, p. 98-101 4 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  6. S3-Leitlinie „Magenkarzinom”: Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs (AWMF-Regist.-Nr. 032-009-OL)

    Moehler, M., Al-Batran, S-E., Andus, T., Anthuber, M., Arends, J., Arnold, D., Aust, D., Baier, P., Baretton, G., Bernhardt, J., Boeing, H., Böhle, E., Bokemeyer, C., Bornschein, J., Budach, W., Burmester, E., Caca, K., Diemer, W. A., Dietrich, C. F., Ebert, M., Eickhoff, A., Ell, C., Fahlke, J., Feussner, H., Fietkau, R., Fischbach, W., Fleig, W., Flentje, M., Gabbert, H. E., Galle, P. R., Geissler, M., Gockel, I., Graeven, U., Grenacher, L., Gross, S., Hartmann, J. T., Heike, M., Heinemann, V., Herbst, B., Herrmann, T., Höcht, S., Hofheinz, R. D., Höfler, H., Höhler, T., Hölscher, A. H., Horneber, M., Hübner, J., Izbicki, J. R., Jakobs, R., Jenssen, C., Kanzler, S., Keller, M., Kiesslich, R., Klautke, G., Körber, J., Krause, B. J., Kuhn, C., Kullmann, F., Lang, H., Link, H., Lordick, F., Ludwig, K., Lutz, M., Mahlberg, R., Malfertheiner, P., Merkel, S., Messmann, H., Meyer, H-J., Mönig, S., Piso, P., Pistorius, S., Porschen, R., Rabenstein, T., Reichardt, P., Ridwelski, K., Röcken, C., Roetzer, I., Rohr, P., Schepp, W., Schlag, P. M., Schmid, R. M., Schmidberger, H., Schmiegel, W-H., Schmoll, H-J., Schuch, G., Schuhmacher, C., Schütte, K., Schwenk, W., Selgrad, M., Sendler, A., Seraphin, J., Seufferlein, T., Stahl, M., Stein, H., Stoll, C., Stuschke, M., Tannapfel, A., Tholen, R., Thuss-Patience, P., Treml, K., Vanhoefer, U., Vieth, M., Vogelsang, H., Wagner, D., Wedding, U., Weimann, A., Wilke, H., Wittekind, C. & AWMF, U., 2011, In: Z GASTROENTEROL. 49, 4, p. 461-531 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Supportivtherapie

    Feyer, P., Bokemeyer, C., Panse, J., Link, H. & Piso, P., 2011, Interdisziplinäre Entscheidungswege in der Onkologie: Diagnose- und Therapiealgorithmen mit Erläuterungen. Deutscher Ärzte-Verlag, p. 187-194 8 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  8. Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.

    Atanackovic, D., Panse, J., Hildebrandt, Y., Jadczak, A., Kobold, S., Cao, Y., Templin, J., Meyer, S., Reinhard, H., Bartels, K., Lajmi, N., Zander, A. R., Marx, A., Bokemeyer, C. & Kröger, N., 2011, In: HAEMATOLOGICA. 96, 10, p. 1512-1520 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Treatment of brain metastases from germ cell tumors.

    Oechsle, K. & Bokemeyer, C., 2011, In: HEMATOL ONCOL CLIN N. 25, 3, p. 605-613 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Treatment of patients with stage II A/B and advanced nonseminomatous germ cell tumors

    Kollmannsberger, C. & Bokemeyer, C., 2011, Cancer of the Testis. Springer Berlin Heidelberg, p. 185-196 12 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  11. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.

    Ummanni, R., Jost, E., Balabanov, M., Lohmann, F., Mundt, F., Barett, C., Schlomm, T., Sauter, G., Senff, T., Bokemeyer, C., Sültmann, H., Meyer-Schwesinger, C., Brümmendorf, T. & Balabanov, S., 2011, In: MOL CANCER. 10, p. 129

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Unusual course of myelodysplastic syndrome with presumed familial origin.

    Bacher, U., Ocheni, S., Schafhausen, P., Oyekunle, A., Dierlamm, J., Zander, A. R., Bokemeyer, C., Haferlach, T. & Kröger, N., 2011, In: ACTA HAEMATOL-BASEL. 126, 4, p. 234-237 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2010

  14. Multimodale Therapiekonzepte von Keimzelltumoren

    Honecker, F., Souchon, R., Krege, S. & Bokemeyer, C., 01.11.2010, In: INTERNIST. 51, 11, p. 1382-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation.

    Mautner, V. F., Nguyen, R., Knecht, R. & Bokemeyer, C., 01.11.2010, In: ANN ONCOL. 21, 11, p. 2294-2295 2 p., 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2

    Mautner, V-F., Nguyen, R., Kutta, H., Fuensterer, C., Bokemeyer, C., Hagel, C., Friedrich, R. E. & Panse, J., 01.01.2010, In: NEURO-ONCOLOGY. 12, 1, p. 14-8 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Studien und personalisierte Medizin in der Onkologie?

    Arnold, D. & Bokemeyer, C., 01.01.2010, In: ONKOLOGIE. 33, 7, p. 25-29 5 p., 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

    Choschzick, M., Lassen, P., Lebeau, A., Marx, A., Terracciano, L., Heilenkötter, U., Jänicke, F., Bokemeyer, C., Izbicki, J. R., Sauter, G. & Simon, R., 2010, In: MODERN PATHOL. 23, 4, p. 603-610 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. [A multi-disciplinary approach to the treatment of germ cell tumors].

    Honecker, F., Souchon, R., Krege, S. & Bokemeyer, C., 2010, In: INTERNIST. 51, 11, p. 1382-1387 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.

    Cao, Y., Gordic, M., Kobold, S., Lajmi, N., Meyer, S., Bartels, K., Hildebrandt, Y., Luetkens, T., Ihloff, A-S., Kröger, N., Bokemeyer, C. & Atanackovic, D., 2010, In: J IMMUNOL METHODS. 358, 1-2, p. 56-65 1-2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Autoantibodies against tumor-related antigens: incidence and biologic significance.

    Kobold, S., Luetkens, T., Cao, Y., Bokemeyer, C. & Atanackovic, D., 2010, In: HUM IMMUNOL. 71, 7, p. 643-651 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Catumaxomab--trifunctional anti-EpCAM antibody used to treat malignant ascites.

    Bokemeyer, C., 2010, In: EXPERT OPIN BIOL TH. 10, 8, p. 1259-1269 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Chemotherapie und systemische Therapie bei Lebermetastasen - Kolorektales Karzinom

    Folprecht, G. & Bokemeyer, C., 2010, Hepatobiliäre und Pankreastumoren. Springer-Verlag GmbH, p. 387-395 9 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Research › peer-review

  24. Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.

    Wiedemann, B., Klyuchnikov, E., Kröger, N., Zabelina, T., Stahl, T., Zeschke, S., Badbaran, A., Ayuketang Ayuk, F., Alchalby, H., Wolschke, C., Bokemeyer, C., Fehse, B., Zander, A. R. & Bacher, U., 2010, In: EXP HEMATOL. 38, 12, p. 1261-1271 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.

    El Gammal, A. T., Brüchmann, M., Zustin, J., Isbarn, H., Hellwinkel, O., Köllermann, J., Sauter, G., Simon, R., Wilczak, W., Schwarz, J., Bokemeyer, C., Brümmendorf, T., Izbicki, J. R., Yekebas, E. F., Fisch, M., Huland, H., Graefen, M. & Schlomm, T., 2010, In: CLIN CANCER RES. 16, 1, p. 56-64 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer.

    Iwanski, G. B., Lee, D. H., En-Gal, S., Doan, N. B., Castor, B., Vogt, M., Toh, M., Bokemeyer, C., Said, J. W., Thoennissen, N. H. & Koeffler, H. P., 2010, In: BRIT J PHARMACOL. 160, 4, p. 998-1007 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.

    Seimetz, D., Lindhofer, H. & Bokemeyer, C., 2010, In: CANCER TREAT REV. 36, 6, p. 458-467 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.

    Thoem, I., Andritzky, B., Schuch, G., Burkholder, I., Edler, L., Johansen, J. S., Bokemeyer, C., Schumacher, U. & Laack, H-E., 2010, In: CANCER-AM CANCER SOC. 116, 17, p. 4114-4121 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.

    Oechsle, K., Bokemeyer, C. & Honecker, F., 2010, In: J CANCER RES CLIN. 136, 1, p. 169 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma.

    Pabst, C., Zustin, J., Jacobsen, F., Luetkens, T., Kröger, N., Schilling, G., Bokemeyer, C., Sauter, G., Atanackovic, D. & Marx, A., 2010, In: EXP MOL PATHOL. 89, 2, p. 175-181 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

    Luetkens, T., Schafhausen, P., Uhlich, F., Stasche, T., Akbulak, R. Ö., Bartels, B. M., Hildebrandt, Y., Gontarewicz, A., Kobold, S., Meyer, S., Gordic, M., Bartels, K., Lajmi, N., Cao, Y., Kröger, N., Bokemeyer, C., Brümmendorf, T. & Atanackovic, D., 2010, In: LEUKEMIA RES. 34, 12, p. 1647-1655 12.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.

    Wermann, H., Stoop, H., Gillis, A. J. M., Honecker, F., Gurp, V., Ruud, J. H. L. M., Ammerpohl, O., Richter, J., Bokemeyer, C., Bokemeyer, C. & Looijenga, L. H. J., 2010, In: J PATHOL. 221, 4, p. 433-442 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers.

    Marx, A., Burandt, E. C., Choschzick, M., Simon, R., Yekebas, E. F., Kaifi, J., Mirlacher, M., Atanackovic, D., Bokemeyer, C., Fiedler, W., Terracciano, L., Sauter, G. & Izbicki, J. R., 2010, In: HUM PATHOL. 41, 11, p. 1577-1585 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.

    Lorch, A., Rick, O., Wündisch, T., Hartmann, J-T., Bokemeyer, C. & Beyer, J., 2010, In: J UROLOGY. 184, 1, p. 168-173 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.

    Marx, A., Zielinski, M., Kowitz, C-M., Dancau, A. M., Thieltges, S., Simon, R., Choschzick, M., Yekebas, E. F., Kaifi, J., Mirlacher, M., Atanackovic, D., Brümmendorf, T., Fiedler, W., Bokemeyer, C., Izbicki, J. R. & Sauter, G., 2010, In: HISTOPATHOLOGY. 57, 3, p. 418-426 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg type.

    Kobold, S., Kilic, N., Luetkens, T., Bokemeyer, C. & Fiedler, W., 2010, In: ACTA HAEMATOL-BASEL. 123, 3, p. 179-181 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.

    Oechsle, K., Bokemeyer, C. & Honecker, F., 2010, In: J CANCER RES CLIN. 136, 1, p. 165-167 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer.

    Laack, H-E., Sauter, G. & Bokemeyer, C., 2010, In: LUNG CANCER. 69, 3, p. 259-264 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

    Minner, S. J. P., Jessen, B., Stiedenroth, L., Burandt, E. C., Köllermann, J., Mirlacher, M., Erbersdobler, A., Eichelberg, C., Fisch, M., Brümmendorf, T., Bokemeyer, C., Simon, R., Steuber, T., Graefen, M., Huland, H., Sauter, G. & Schlomm, T., 2010, In: CLIN CANCER RES. 16, 5, p. 1553-1560 5.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Organprotektion in der Tumortherapie - mit Medikamenten vor unerwünschten Wirkungen schützen

    Oechsle, K. & Bokemeyer, C., 2010, In: Im Fokus Onkologie. 12, p. 43-47

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Patients with advanced non-seminomatous germ-cell tumour: the art of the start.

    Honecker, F. & Bokemeyer, C., 2010, In: ANN ONCOL. 21, 8, p. 1569-1571 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor.

    Oechsle, K., Lorch, A., Honecker, F., Kollmannsberger, C., Hartmann, J. T., Boehlke, I., Beyer, J. & Bokemeyer, C., 2010, In: ONCOLOGY-BASEL. 78, 1, p. 47-53 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Prognostic and diagnostic value of spontaneous tumor-related antibodies.

    Kobold, S., Luetkens, T., Cao, Y., Bokemeyer, C. & Atanackovic, D., 2010, In: Clin Dev Immunol. 2010, p. 721531

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.

    Oechsle, K., Lange-Brock, V., Krüll, A., Bokemeyer, C. & De Wit, M., 2010, In: J CANCER RES CLIN. 136, 11, p. 1729-1735 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.

    Mesía, R., Rivera, F., Kawecki, A., Rottey, S., Hitt, R., Kienzer, H., Cupissol, D., De Raucourt, D., Benasso, M., Koralewski, P., Delord, J-P., Bokemeyer, C., Curran, D., Gross, A. & Vermorken, J. B., 2010, In: ANN ONCOL. 21, 10, p. 1967-1973 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., Debus, J., Eble, M. J., Sökler, M., Ho, A., Rank, A., Ganser, A., Trümper, L., Bokemeyer, C., Kirchner, H., Schubert, J., Král, Z., Fuchs, M., Müller-Hermelink, H-K., Müller, R-P. & Diehl, V., 2010, In: NEW ENGL J MED. 363, 7, p. 640-652 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?

    Wellbrock, J., Bokemeyer, C. & Fiedler, W., 2010, In: J Oncol. 2010, p. 317068

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.

    Cao, Y., Luetkens, T., Kobold, S., Hildebrandt, Y., Gordic, M., Lajmi, N., Meyer, S., Bartels, K., Zander, A. R., Bokemeyer, C., Kröger, N. & Atanackovic, D., 2010, In: EXP HEMATOL. 38, 10, p. 860-867 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Therapie von Hodentumoren: Stadienspezifisch und leitliniengerecht behandeln

    Honecker, F., Souchon, R., Krege, S. & Bokemeyer, C., 2010, In: best pract onkol. 5, 1, p. 4-13 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial.

    Heiss, M. M., Murawa, P., Koralewski, P., Kutarska, E., Kolesnik, O. O., Ivanchenko, V. V., Dudnichenko, A. S., Aleknaviciene, B., Razbadauskas, A., Gore, M., Ganea-Motan, E., Ciuleanu, T., Wimberger, P., Schmittel, A., Schmalfeldt, B., Burges, A., Bokemeyer, C., Lindhofer, H., Lahr, A. & Parsons, S. L., 2010, In: INT J CANCER. 127, 9, p. 2209-2221 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Unterschätztes Risiko - Kardiotoxizität onkologischer Therapien

    Oechsle, K. & Bokemeyer, C., 2010, In: Im Fokus Onkologie. 7, 8, p. 49-53 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Y chromosome loss is a frequent early event in urothelial bladder cancer.

    Minner, S. J. P., Kilgué, A., Stahl, P., Weikert, S., Rink, M., Dahlem, R., Fisch, M., Höppner, W., Wagner, W., Bokemeyer, C., Terracciano, L., Simon, R., Sauter, G. & Wilczak, W., 2010, In: PATHOLOGY. 42, 4, p. 356-359 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1...9 10 11 12 13 14 15 16 Next